FDA approves Bayer’s Nubeqa (darolutamide), a new treatment for men with non-metastatic castration-resistant prostate cancer Read more
Pfizer Announces Closing of Joint Venture With GlaxoSmithKline to Create a Premier Global Consumer Healthcare Company Read more
Endo Appoints Domenico Ciarico as Executive Vice President and Chief Commercial Officer, Sterile and Generics Read more
NIIMBL and FDA Sign New Agreement to Support Advanced Innovation in Biopharmaceutical Manufacturing Read more
Novartis Kisqali significantly prolongs life in women with HR+/HER2- advanced breast cancer now in two distinct Phase III trials Read more